Your browser doesn't support javascript.
loading
Phase 2 randomized clinical trial of astegolimab in patients with moderate to severe atopic dermatitis.
Maurer, Marcus; Cheung, Dorothy S; Theess, Wiebke; Yang, Xiaoying; Dolton, Michael; Guttman, Anna; Choy, David F; Dash, Ajit; Grimbaldeston, Michele A; Soong, Weily.
  • Maurer M; Fraunhofer Institute for Translational Medicine and Pharmacology, Allergology and Immunology, Berlin, Germany; Institute of Allergology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany. Electronic address: marcus.ma
  • Cheung DS; Genentech, Inc, South San Francisco, Calif.
  • Theess W; F Hoffmann-LaRoche, Basel, Switzerland.
  • Yang X; Genentech, Inc, South San Francisco, Calif.
  • Dolton M; Roche Products Australia, Millers Point, Australia.
  • Guttman A; Genentech, Inc, South San Francisco, Calif.
  • Choy DF; Genentech, Inc, South San Francisco, Calif.
  • Dash A; Genentech, Inc, South San Francisco, Calif.
  • Grimbaldeston MA; Genentech, Inc, South San Francisco, Calif.
  • Soong W; Alabama Allergy and Asthma Center and Clinical Research Center of Alabama, Birmingham, Ala.
J Allergy Clin Immunol ; 150(6): 1517-1524, 2022 12.
Article en En | MEDLINE | ID: mdl-36041655
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Dermatitis Atópica / Anticuerpos Monoclonales Humanizados Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Dermatitis Atópica / Anticuerpos Monoclonales Humanizados Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article